HALEON US HOLDINGS LLC
Lobbying for HALEON US HOLDINGS LLC · Consumer health care company
General review and monitoring of issues and administrative actions related to the design, development, and deployment of artificial intelligence platforms, especially as related to healthcare, over the counter settings, and protection of personally identifiable information.
General monitoring of issues and administrative action related to intellectual property protection.
General monitoring and review of issues and executive actions related to or impacting multivitamins and nutrition.
General review of federal policies applying towards paid family and medical leave; and General review of issues and administration action related to pediatric over-the-counter medication concerns.
General review and monitoring of processes impacting over-the-counter switches, including Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) rulemaking process
General review and monitoring on efforts aimed at preventing youth consumption of tobacco products; General review and monitoring of smoking cessation and over-the-counter alternatives for adult consumers.
General review and monitoring of legislative and regulatory proposals impacting Infrastructure Investment and Jobs Act (P.L. 117-58), and the Inflation Reduction Act of 2022 (P.L. 117-169); and Review and monitoring of Congressional appropriations-specifically on report language related to FSA/HSA eligibility of specialty toothpastes/rinses and dietary supplements
General monitoring of legislative and administrative action related to health care policy; including the OTC Monograph Drug User Fee Program (OMUFA). General monitoring of legislative and administrative action related to womens health issues; General monitoring of legislative and administrative action related to over-the-counter consumer healthcare products; General monitoring of legislative and administrative action related to dietary supplements, multivitamin, and hunger issues; General monitoring of legislative and administrative action related to FDA monograph reform and user fees; General monitoring of legislative and administrative action related to the switch of prescription medications to over-the-counter medications; Review of coverage for medically necessary services in Medicare and Medicare Advantage, General review and monitoring of processes impacting over-the-counter switches, including Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) rulemaking process; Review of issues impacting the Dietary Supplement Health and Education Act of 1994; General review of issues and amendments focusing on non-addictive, non-opioid pain management medications, with a focus on over-the-counter (OTC) options; and Monitoring of regulatory proposals impacting inclusion of routine non-pediatric dental services as Essential Health Benefits (EHBs)
General monitoring of legislative and administrative action related to Medicare and Medicaid policy, including changes in coverage/eligibility; General monitoring of Medicare coverage of dental services; and General review of issues and rulemaking impacting dual eligible enrollees.
Implementation of H.R. 3684, Infrastructure Investment and Jobs Act; General monitoring of issues related to federal tax amortization of research and development expenses; General review and monitoring of issues that includes over-the-counter dietary supplement products, specifically multivitamins, as qualified medical expenses; General review and monitoring of issues and administrative action related to oral healthcare products, including specialty toothpastes and rinses, as qualified medical expenses under HSA/FSA; Continued monitor and review of fiscal year (FY) 2025 budget resolution in both House and Senate, along with associated reconciliation instructions.
General monitoring and review of legislative and executive actions on international trade policy related to tariffs, import/export concerns; General monitoring of legislative and administrative action related to review of the United States-Mexico-Canada Agreement (USMCA); and General review and monitoring of global supply chain concerns
General issues related to the manufacturing and supply chain resiliency of over-the-counter medications; General monitor and review of issues and administrative action related to domestic supply chain and manufacturing capabilities.
General review and monitoring of nutrition and dietary supplement trends with the U.S. military.
General monitoring of issues and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of issues and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings.
General review and monitoring of renewable energy issues and regulations.
General review and monitoring of U.S. diplomatic relations.